A carregar...
Combined modality therapy with TRAIL or agonistic death receptor antibodies
Molecularly targeted therapies, such as antibodies and small molecule inhibitors have emerged as an important breakthrough in the treatment of many human cancers. One targeted therapy under development is tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) due to its ability to induce ap...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Landes Bioscience
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3087899/ https://ncbi.nlm.nih.gov/pubmed/21263219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.11.5.14671 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|